Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cδ/P38 mitogen-activated protein kinase and JNK/nuclear factor-k{cyrillic}B-dependent matrix metalloproteinase-9 expression

Molecular Nutrition and Food Research

Volumn 54, Issue 7, 2010, Pages 977-990

  Hwang, Yong Pil ^a   Jeongyun, Hyo ^a   Choi, Jae Ho ^a   Kang, Keonwook ^a   Jeong, Hye Gwang ^a,b  

^a Chosun University   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Antitumor activity; Bergamottin; Invasion; Matrix metalloproteinases 9; Nuclear factor k cyrillic B

Indexed keywords

ANTINEOPLASTIC AGENT; BERGAMOTTIN; CARCINOGEN; CYTOCHROME P450; DRUG DERIVATIVE; GELATINASE A; GELATINASE B; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOLOL MYRISTATE ACETATE; PRKCD PROTEIN, HUMAN; PROTEIN KINASE C DELTA; PSORALEN DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CANCER INVASION; CELL MOTION; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; FIBROSARCOMA; GENETICS; HUMAN; METABOLISM; OSMOLARITY; PATHOLOGY; PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOGENS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOCHROME P-450 ENZYME SYSTEM; DOWN-REGULATION; FIBROSARCOMA; HUMANS; I-KAPPA B PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NF-KAPPA B; OSMOLAR CONCENTRATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE C-DELTA; PROTEIN TRANSPORT; PSORALENS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE;

CITRUS; CITRUS X PARADISI; PHOS;

EID: 77954642557     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900283     Document Type: Article

References (53)

1. Block, G., Patterson, B., Subar, A., Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer 1992, 18, 1-29.
2. Miyata, M., Takano, H., Takahashi, K., Sasaki, Y. F., Yama-zoe, Y., Suppressionof 2-amino-1-methyl-6-phenylimi-dazo[4,5-b]pyridine-induced DNA damage in rat colon after grapefruit juice intake. Cancer Lett. 2002, 183, 17-22.
3. Nogata, Y., Sakamoto, K., Shiratsuchi, H., Ishii, T. et al., Flavonoid composition of fruit tissues of citrus species. Biosci. Biotechnol. Biochem. 2006, 70, 178-192.
4. Steinmetz, K. A., Potter, J. D., Vegetables, fruit, and cancer prevention: a review. J. Am. Diet. Assoc. 1996, 96, 1027-1039.
5. Fukuda, K., Ohta, T., Oshima, Y., Ohashi, N. et al., Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogenetics 1997, 7, 391-396.
6. Schmiedlin-Ren, P., Edwards, D. J., Fitzsimmons, M. E., He, K. et al., Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents: decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab. Dispos. 1997, 25, 1228-1233.
7. He, K., Woolf, T. F., Hollenberg, P. F., Mechanism-based inactivation of cytochrome P450 3A4 by mifepristone (RU486). J. Pharmarcol. Exp. Ther. 1999, 288, 791-797.
8. Baumgart, A., Schmidt, M., Schmitz, H. J., Schrenk, D., Natural furocoumarins as inducers and inhibitors of cyto-chrome P450 1A1 in rat hepatocytes. Biochem. Pharmacol. 2005, 69, 657-667.
9. Lin, H. L., Kent, U. M., Hollenberg, P. F., The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5. J. Pharmacol. Exp. Ther. 2005, 313, 154-164.
10. Kleiner, H. E., Reed, M. J., DiGiovanni, J., Naturally occurring coumarins inhibit human cytochromes P450 and block benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene DNA adduct formation in MCF-7 cells. Chem. Res. Toxicol. 2003, 16, 415-422.
11. Cai, Y., Kleiner, H., Johnston, D., Dubowski, A. et al., Effect of naturally occurring coumarins on the formation of epidermal DNA adducts and skin tumors induced by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in SENCAR mice. Carcinogenesis 1997, 18, 1521-1527.
12. Murakami, A., Gao, G., Kim, O. K., Omura, M. et al., Identification of coumarins from the fruit of Citrus hystrix DC as inhibitors of nitric oxide generation in mouse macrophage RAW 264.7 cells. J. Agric. Food Chem. 1999, 47, 333-339.
13. Kawaii, S., Tomono, Y., Katase, E., Ogawa, K., Yano, M., Isolation of furocoumarins from bergamot fruits as HL-60 differentiation-inducing compounds. J. Agric. Food Chem. 1999, 47, 4073-4078.
14. Sekiguchi, H., Washida, K., Murakami, A., Suppressive effects of selected food phytochemicals on CD74 expression in NCI-N87 gastric carcinoma cells. J. Clin. Biochem. Nutr. 2008, 43, 109-117.
15. Sasaki, M., Elrod, J. W., Jordan, P., Itoh, M. et al., CYP450 dietary inhibitors attenuate TNF-alpha-stimulated endothe-lial molecule expression and leukocyte adhesion. Am. J. Physiol. Cell Physiol. 2004, 286, C931-C939.
16. Liotta, L. A., Steeg, P. S., Stetler-Stevenson, W. G., Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64, 327-336.
17. Deryugina, E. I., Luo, G. X., Reisfeld, R. A., Bourdon, M. A., Strongin, A., Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anti-cancer Res. 1997, 17,3201-3210.
18. Johnson, L. L., Dyer, R., Hupe, D. J., Matrix metalloprotei-nases. Curr. Opin. Chem. Biol. 1998, 2, 466-471.
19. Woessner, J. F., Jr., Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991, 5, 2145-2154.
20. Mignatti, P., Rifkin, D. B., Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 1993, 73, 161-195.
21. Westermarck, J., Kahari, V. M., Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999, 13, 781-792.
22. Morris, V. L., Chan, B. M., Interaction of epidermal growth factor, Ca2ρ, and matrix metalloproteinase-9 in primary keratinocyte migration. Wound Repair Regen. 2007, 15, 907-915.
23. Yan, C., Boyd, D. D., Regulation of matrix metalloproteinase gene expression. J. Cell. Physiol. 2007, 211, 19-26.
24. Salo,T., Makela, M., Kylmäniemi, M., Autio-Harmainen, H., Larjava, H., Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab. Invest. 1994, 70, 176-182.
25. Johnsen, M., Lund, L. R., Romer, J., Almholt, K., Dano, K., Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr. Opin. Cell. Biol. 1998, 10, 667-671.
26. Liabakk, N. B., Talbot, I., Smith, R. A., Wilkinson, K., Balkwill, F., Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res. 1996, 56, 190-196.
27. Cho, H. J., Kang, J. H., Kwak, J. Y., Lee, T. S. et al., Asco-furanone suppresses PMA-mediated matrix metalloprotei-nase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis 2007, 28, 1104-1110.
28. Kajanne, R., Miettinen, P., Mehlem, A., Leivonen, S. K. etal., EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J. Cell. Physiol. 2007, 212, 489-497.
29. Srivastava, A. K., Qin, X., Wedhas, N., Arnush, M. et al., Tumor necrosis factor-alpha augments matrix metallopro-teinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway. J. Biol. Chem. 2007, 282, 35113-35124.
30. Egeblad, M., Werb, Z., New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2, 161-174.
31. Forget, M. A., Desrosiers, R. R., Beliveau, R., Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis. Can. J. Physiol. Pharmacol. 1999, 77, 465-480.
32. Visse, R., Nagase, H., Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 2003, 92, 827-839.
33. Kim, D., Kim, S., Koh, H., Yoon, S. O. et al., Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J. 2001, 15, 1953-1962.
34. Sato, T., Koike, L., Miyata, Y., Hirata, M. et al., Inhibition of activator protein-1 binding activityand phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metallopro-teinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells. Cancer Res. 2002, 62, 1025-1029.
35. Shin, Y., Yoon, S. H., Choe, E. Y., Cho, S. H. et al., PMA-induced up-regulation of MMP-9 is regulated by a PKCal-pha-NF-kappaB cascade in human lung epithelial cells. Exp. Mol. Med. 2007, 39, 97-105.
36. Takada, Y., Singh, S., Aggarwal, B. B., Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappa B-mediated gene expression and up-regulation of apoptosis. J. Biol. Chem. 2004, 279, 15096-15104.
37. Pahl, H. L., Activators and target genes of Rel/NF-kB transcription factors. Oncogene 1999, 18, 6853-6866.
38. Garg, A., Aggarwal, B. B., Nuclear transcription factor-k{cyrillic}Bas a target for cancer drug development. Leukemia 2002, 16, 1053-1068.
39. Blackburn, J. S., Rhodes, C. H., Coon, C. I., Brinckerhoff, C. E., RNA interference inhibition of matrix metalloprotei-nase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis. Cancer Res. 2007, 67, 10849-10858.
40. Kunigal, S., Lakka, S. S., Gondi, C. S., Estes, N., Rao, J. S., RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth. Int. J. Cancer 2007, 121, 2307-2316.
41. Ngameni, B., Touaibia, M., Patnam, R., Belkaid, A. et al., Inhibition of MMP-2 secretion from brain tumor cells suggests chemopreventive properties of a furanocoumarin glycoside and of chalcones isolated from the twigs of Dorstenia turbinata. Phytochemistry 2006, 67, 2573-2579.
42. Shen, S. C., Lin, C. W., Lee, H. M., Chien, L. L., Chen, Y. C., Lipopolysaccharide plus 12-o-tetradecanoylphorbol 13-acetate induction of migration and invasion of glioma cells in vitro and in vivo: differential inhibitory effects of flavo-noids. Neuroscience 2006, 140, 477-489.
43. Woo, J. H., Park, J. W., Lee, S. H., Kim, Y. H. et al., Dykellic acid inhibits phorbol myristate acetateinduced matrix metalloproteinase-9 expression by inhibiting nuclear factor kappa B transcriptional activity. Cancer Res. 2003, 63, 3430-3434.
44. Hong, S., Park, K. K., Magae, J., Ando, K. et al., Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells. J. Biol. Chem. 2005, 280, 25202-25209.
45. Lee, S. O., Jeong, Y. J., Im, H. G., Kim, C. H. etal., Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells. Biochem. Biophys. Res. Commun. 2007, 354, 165-171.
46. Zhang, J., Protein kinase C (PKC) betaII induces cell invasion through a Ras/Mek-, PKC iota/Rac 1-dependent signaling pathway. J. Biol. Chem. 2004, 279, 22118-22123.
47. Nguyen, M., Arkell, J., Jackson, C. J., Activated protein C directly activates human endothelial gelatinase A. J. Biol. Chem. 2000, 275, 9095-9098.
48. Chung, T. W., Moon, S. K., Chang, Y. C., Ko, J. H. et al., Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEBJ. 2004, 18, 1123-1125.
49. Kobayashi, T., Kishimoto, J., Ge, Y., Jin, W. et al., A novel mechanism of matrix metalloproteinase-9 gene expression implies a role for keratinization. EMBO Rep. 2001, 2, 604-608.
50. Scorilas, A., Karkmeris, A., Arnogiannaki, N., Ardvanis, A. et al., Overexpression of matrixmetalloproteinase-9 in human breast cancer: a potential favorable indicator in node-negative patients. Br. J. Cancer 2001, 84, 1488-1496.
51. Sato, H., Takino, T., Okada, Y., Cao, J. et al., A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994, 370, 61-65.
52. Hofmann, J., Protein kinase C isozymes as potential targets for anticancer therapy. Curr. Cancer Drug Targets 2004, 4,125-146.
53. Woo, J. H., Lim, J. H., Kim,Y. H.,Suh,S. I. et al., Resveratrol inhibits phorbol myristate acetate-induced matrix metallo-proteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 2004, 23, 1845-1853.